Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
PHATHOM PHARMACEUTICALS INC
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the commercialization and development of novel treatments for gastrointestinal diseases. It has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) for the United States (U.S.), Europe and Canada. PCABs are a novel class of molecules that block acid secretion in the stomach. The Company markets vonoprazan in the U.S. as VOQUEZNA (vonoprazan) tablets for the relief of heartburn associated with non-erosive gastroesophageal reflux disease (Non-Erosive GERD) in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, and as part of VOQUEZNA DUAL PAK (vonoprazan tablets, amoxicillin capsules) and VOQUEZNA TRIPLE PAK (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) for the treatment of H. pylori infection in adults.
Find out what a historical investment in PHATHOM PHARMACEUTICALS INC would be worth today using our PHAT stock calculator.
Market Capitalisation
$783.20M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
0
High today
$10.26
Low today
$9.74
Open price
$0.00
52-week high
$18.31
52-week low
$7.61
Ready to start your investing journey with Stake?
Open an accountHow do I buy PHAT shares in Australia?
Buying PHAT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in PHATHOM PHARMACEUTICALS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PHAT
What is the ticker symbol of PHATHOM PHARMACEUTICALS INC?
The ticker symbol for PHATHOM PHARMACEUTICALS INC is PHAT.
How much is one share of PHAT?
One share of PHAT is valued at $9.96 as of 11 June 2026.
What is the market capitalisation of PHATHOM PHARMACEUTICALS INC PHAT?
As of 11 June 2026 PHATHOM PHARMACEUTICALS INC has a market cap of $783.20M.
What is the 52-week high for PHATHOM PHARMACEUTICALS INC stock?
The PHATHOM PHARMACEUTICALS INC 52-week high stock price is $18.31.
What is the 52-week low for PHATHOM PHARMACEUTICALS INC stock?
The PHATHOM PHARMACEUTICALS INC 52-week low stock price is $7.61.
Can I buy PHAT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy PHAT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PHAT on Stake
- Buy PHAT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PHAT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PHAT related stocks